| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 02/12/2021 | 12:03PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 02/11/2021 | 5:12PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 02/10/2021 | 5:23PM | GlobeNewswire Inc. | Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters... | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 02/04/2021 | 9:49PM | GlobeNewswire Inc. | Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 02/04/2021 | 10:15AM | Edgar (US Regulatory) | Schedule 13g | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 02/03/2021 | 5:13PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 02/03/2021 | 4:43PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 02/03/2021 | 4:01PM | GlobeNewswire Inc. | Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 02/01/2021 | 8:34AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 01/26/2021 | 7:00AM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Announces Positive Data with Setmelanotide in Additional MC4R Pathway Deficiency-related Obesities | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 01/19/2021 | 8:00AM | GlobeNewswire Inc. | Rhythm Pharmaceuticals to Provide Update on Phase 2 Basket Study and Genetic Sequencing Efforts | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 01/05/2021 | 4:50PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 01/05/2021 | 8:16AM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 01/05/2021 | 8:00AM | PR Newswire (US) | Pharvaris Expands Board of Directors with Appointment of David Meeker, M.D., as Chair and Robert Glassman, M.D., as Director | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 12/22/2020 | 7:00AM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bar... | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 12/11/2020 | 4:11PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 12/11/2020 | 4:11PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 12/11/2020 | 4:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 12/11/2020 | 8:15AM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directo... | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 12/04/2020 | 4:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 11/27/2020 | 7:30AM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Managem... | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 11/10/2020 | 4:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 11/10/2020 | 4:06PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 11/04/2020 | 4:30PM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Announces New Clinical Data on Setmelanotide at ObesityWeek® 2020 | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 11/02/2020 | 11:35AM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 11/02/2020 | 9:33AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 11/02/2020 | 8:00AM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 10/30/2020 | 7:30PM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes ... | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |
| 10/28/2020 | 8:00AM | GlobeNewswire Inc. | Rhythm Pharmaceuticals Appoints Jennifer Chien as Executive Vice President, Head of North America | NASDAQ:RYTM | Rhythm Pharmaceuticals Inc |